VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.

The Cottage Heart & Vascular Center’s structural heart team at Santa Barbara Cottage Hospital (SBCH) recently performed their 1,000th WATCHMAN device procedure, a minimally invasive solution for ...

Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation ...

Asymptomatic AFib is a silent condition, so it often goes undetected until a routine physical, smart technology alert, or a medical emergency, such as a stroke or heart failure, occurs. For Black ...

Abbott today announced positive early results from a study evaluating its investigational Amulet 360 left atrial appendage (LAA) occluder.

Abbott Park, Illinois Monday, February 9, 2026, 13:00 Hrs [IST] ...

A landmark clinical trial from St Bartholomew’s Hospital reveals that the Apple Watch detects recurring AFib faster and reduces unplanned hospitalizations by half following catheter ablation.

Medtronic has secured a CE mark approval in Europe for its surgical implant to close the heart’s left atrial appendage, aimed at reducing the long-term risk of stroke that’s higher among people with ...

Livingston, N.J.-based Cooperman Barnabas Medical Center cardiologists recently completed their 500th left atrial appendage closure device implant for patients with atrial fibrillation, ...

LAKE CHARLES, La. (KPLC) - A big milestone happened over at CHRISTUS Ochsner St. Patrick Hospital this week. Their cardiology team announced they have implanted 500 Watchman devices for patients with ...

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it. Whenever he’d overexert himself, he’d feel “different,” but it would go away with rest.

Previously, patients with advanced atrial fibrillation (AF/AFib) had limited treatment choices. Since February 2024, West ...